Unlike other SARS-CoV-2 variants, the delta variant can attach to copies of itself, forming larger aggregations, or clumps, of viral particles, suggests a study by scientists at the National Institutes of Health. The researchers ...
May 11, 2022
0
7
No one's exactly sure what causes Bell's palsy, a condition that causes sudden facial weakness on one side of the face. But the symptoms are unmistakable. Once the weakness, or paralysis, sets in—usually on one side of ...
May 9, 2022
0
5
An antiviral drug used to treat high-risk COVID-19 patients may also benefit patients with long COVID, researchers say.
May 6, 2022
0
13
COVID-19 vaccines have saved at least a million lives in the United States alone, but for many people, a lingering fear remains: If—or when—they get hit by the coronavirus, just how bad will it be? Will they breeze through ...
May 5, 2022
0
135
Pfizer executives said Tuesday they are confident of strong demand for the company's COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.
May 3, 2022
0
5
The World Health Organization said Friday it "strongly recommended" Pfizer's COVID-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalization.
Apr 21, 2022
0
73
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat ...
Apr 13, 2022
0
155
While 2021 proved to be a record-breaking year for organ donation in the U.S., many people are still hesitant to register to become a donor. Nationwide, only about 48% of people are registered to be organ donors, according ...
Apr 6, 2022
0
10
The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart's rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill ...
Apr 1, 2022
0
41
Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of Infectious Diseases. However, widespread use of currently ...
Mar 31, 2022
0
73
